These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6966932)

  • 41. Deoxy-ATP accumulation in adenosine deaminase-inhibited human B and T lymphocytes.
    Gruber HE; Cohen AH; Firestein GS; Redelman D; Bluestein HG
    Adv Exp Med Biol; 1986; 195 Pt A():503-7. PubMed ID: 3487921
    [No Abstract]   [Full Text] [Related]  

  • 42. 2'-deoxycoformycin toxicity in murine spleen lymphocytes.
    Earle MF; Glazer RI
    Mol Pharmacol; 1983 Jan; 23(1):165-70. PubMed ID: 6602939
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study on the inhibition of adenosine deaminase.
    Montgomery JA; Thomas HJ; Zell AL; Einsphar HM; Bugg CE
    J Med Chem; 1985 Nov; 28(11):1751-3. PubMed ID: 4068002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on the effect of deoxyadenosine on deoxycoformycin-treated myeloid and lymphoid stem cells.
    Aye MT; Dunne JV; Yang WC
    Blood; 1982 Oct; 60(4):872-6. PubMed ID: 6981441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opposite effects of recombinant interferon-alpha A and deoxycoformycin on adenosine deaminase activity in the Daudi B lymphoblastoid cell line.
    Faltynek CR
    Blood; 1988 Jan; 71(1):59-64. PubMed ID: 3257147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Production of 2'-deoxycoformycin by the fungus Emericella nidulans and its inhibitory effect on adenosine deaminase.
    Kanbe T; Endo A; Hashizume T
    Nucleic Acids Symp Ser; 1983; (12):115-8. PubMed ID: 6607458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
    Bagnara AS; Hershfield MS
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency.
    Ratech H; Hirschhorn R; Thorbecke GJ
    Am J Pathol; 1985 Apr; 119(1):65-72. PubMed ID: 3872599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitors of adenosine deaminase.
    Agarwal RP
    Pharmacol Ther; 1982; 17(3):399-429. PubMed ID: 6187032
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin.
    Cummings FJ; Crabtree GW; Wiemann MC; Spremulli EN; Parks RE; Calabresi P
    Clin Pharmacol Ther; 1988 Nov; 44(5):501-9. PubMed ID: 3263248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The biochemical pharmacology of (2'-R)-chloropentostatin, a novel inhibitor of adenosine deaminase.
    Jackson RC; Leopold WR; Ross DA
    Adv Enzyme Regul; 1986; 25():125-39. PubMed ID: 2433905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased adenosine deaminase synthesis and messenger RNA activity in deoxycoformycin-resistant cells.
    Hunt SW; Hoffee PA
    J Biol Chem; 1983 Jan; 258(1):41-4. PubMed ID: 6600234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro effects of adenosine deaminase inhibitors on lymphocyte mitogen responsiveness in the mouse.
    Ballow M; Pantschenko AG
    Cell Immunol; 1981 Oct; 64(1):29-43. PubMed ID: 6975175
    [No Abstract]   [Full Text] [Related]  

  • 55. The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Smyth JF; Paine RM; Jackman AL; Harrap KR; Chassin MM; Adamson RH; Johns DG
    Cancer Chemother Pharmacol; 1980; 5(2):93-101. PubMed ID: 6970630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo toxicity to lymphoid tissue by 2'-deoxycoformycin.
    Smyth JF; Young RC; Young DM
    Cancer Chemother Pharmacol; 1978; 1(1):49-51. PubMed ID: 750104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deoxycoformycin resistant mammalian cells that overproduce adenosine deaminase.
    Hoffee PA; Hunt SW
    Adv Exp Med Biol; 1984; 165 Pt A():405-10. PubMed ID: 6609531
    [No Abstract]   [Full Text] [Related]  

  • 58. Adenosine deaminase inhibitors. Synthesis and biological evaluation of (+/-)-3,6,7,8-tetrahydro-3-[(2-hydroxyethoxy)methyl]imidazo[4,5-d] [1,3]diazepin-8-ol and some selected C-5 homologues of pentostatin.
    Showalter HD; Putt SR; Borondy PE; Shillis JL
    J Med Chem; 1983 Oct; 26(10):1478-82. PubMed ID: 6604819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spontaneous epimerization of (S)-deoxycoformycin and interaction of (R)-deoxycoformycin, (S)-deoxycoformycin, and 8-ketodeoxycoformycin with adenosine deaminase.
    Schramm VL; Baker DC
    Biochemistry; 1985 Jan; 24(3):641-6. PubMed ID: 3873254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of isocoformycin, an adenosine deaminase inhibitor of synthetic origin.
    Shimazaki M; Kondo S; Maeda K; Ohno M; Umezawa H
    J Antibiot (Tokyo); 1979 May; 32(5):537-8. PubMed ID: 528399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.